Karki S, Sun W, Madan R, Lamsal K, Schmitt S, Godwin A
Fortune J Health Sci. 2023; 6(2):167-173.
PMID: 37736078
PMC: 10512748.
DOI: 10.26502/fjhs.112.
Schamschula E, Kinzel M, Wernstedt A, Oberhuber K, Gottschling H, Schnaiter S
Biomolecules. 2022; 12(10).
PMID: 36291559
PMC: 9599501.
DOI: 10.3390/biom12101350.
Lamichhane S, Mo J, Sharma G, Joung S, Chae S
Am J Cancer Res. 2022; 12(7):3223-3241.
PMID: 35968353
PMC: 9360235.
Mezzapesa M, Losurdo G, Celiberto F, Rizzi S, dAmati A, Piscitelli D
Int J Mol Sci. 2022; 23(8).
PMID: 35457279
PMC: 9032676.
DOI: 10.3390/ijms23084461.
Philipovskiy A, Ghafouri R, Dwivedi A, Alvarado L, McCallum R, Maegawa F
Front Oncol. 2022; 11:772225.
PMID: 35141142
PMC: 8819001.
DOI: 10.3389/fonc.2021.772225.
Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis.
Hoskins B, Wasuwanich P, Scheimann A, Karnsakul W
World J Gastrointest Oncol. 2021; 13(9):1121-1131.
PMID: 34616517
PMC: 8465437.
DOI: 10.4251/wjgo.v13.i9.1121.
The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population.
Mehrzad J, Dayyani M, Erfanian-Khorasani M
Med J Islam Repub Iran. 2020; 34:75.
PMID: 33306066
PMC: 7711031.
DOI: 10.34171/mjiri.34.75.
Treating Colorectal Cancer with Immunotherapy: Implications for Single versus Combination Therapy.
Karki S, Umar S, Kasi A
Curr Colorectal Cancer Rep. 2020; 16(5):107-117.
PMID: 33132786
PMC: 7594761.
DOI: 10.1007/s11888-020-00459-y.
Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer.
Vafaei S, Roudi R, Madjd Z, Aref A, Ebrahimi M
Cancer Cell Int. 2020; 20:288.
PMID: 32655320
PMC: 7339440.
DOI: 10.1186/s12935-020-01389-3.
Cystic Fibrosis, CFTR, and Colorectal Cancer.
Scott P, Anderson K, Singhania M, Cormier R
Int J Mol Sci. 2020; 21(8).
PMID: 32326161
PMC: 7215855.
DOI: 10.3390/ijms21082891.
Exploring geographical differences in the incidence of colorectal cancer in the Norwegian Women and Cancer Study: a population-based prospective study.
Oyeyemi S, Braaten T, Botteri E, Berstad P, Borch K
Clin Epidemiol. 2019; 11:669-682.
PMID: 31496822
PMC: 6691490.
DOI: 10.2147/CLEP.S207413.
The Role of TGF-β and Its Receptors in Gastrointestinal Cancers.
Luo J, Chen X, Li P
Transl Oncol. 2018; 12(3):475-484.
PMID: 30594036
PMC: 6314240.
DOI: 10.1016/j.tranon.2018.11.010.
The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy.
Nguyen H, Duong H
Oncol Lett. 2018; 16(1):9-18.
PMID: 29928381
PMC: 6006272.
DOI: 10.3892/ol.2018.8679.
Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
Schmit S, Edlund C, Schumacher F, Gong J, Harrison T, Huyghe J
J Natl Cancer Inst. 2018; 111(2):146-157.
PMID: 29917119
PMC: 6555904.
DOI: 10.1093/jnci/djy099.
TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome.
Gray P, Tsai P, Chen D, Wu S, Hoo J, Mu W
Oncotarget. 2018; 9(29):20304-20322.
PMID: 29755653
PMC: 5945525.
DOI: 10.18632/oncotarget.24854.
Genome-wide association study of colorectal cancer in Hispanics.
Schmit S, Schumacher F, Edlund C, Conti D, Ihenacho U, Wan P
Carcinogenesis. 2016; 37(6):547-556.
PMID: 27207650
PMC: 4876992.
DOI: 10.1093/carcin/bgw046.
A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study.
Schmit S, Schumacher F, Edlund C, Conti D, Raskin L, Lejbkowicz F
Carcinogenesis. 2014; 35(11):2512-9.
PMID: 25023989
PMC: 4271131.
DOI: 10.1093/carcin/bgu148.
A functional polymorphism rs11614913 in microRNA-196a2 is associated with an increased risk of colorectal cancer although not with tumor stage and grade.
Wang N, Li Y, Zhu L, Zhou R, Jin W, Guo X
Biomed Rep. 2014; 1(5):737-742.
PMID: 24649020
PMC: 3917088.
DOI: 10.3892/br.2013.146.
Cancer risk assessment using genetic panel testing: considerations for clinical application.
Hiraki S, Rinella E, Schnabel F, Oratz R, Ostrer H
J Genet Couns. 2014; 23(4):604-17.
PMID: 24599651
DOI: 10.1007/s10897-014-9695-6.
The burden of faulty proofreading in colon cancer.
Seshagiri S
Nat Genet. 2013; 45(2):121-2.
PMID: 23358219
DOI: 10.1038/ng.2540.